Inhibitor Therapeutics, Inc. Accounts Payable
Inhibitor Therapeutics, Inc. (INTI) had Accounts Payable of $139.05 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $139.05K.
- 2026-03-31: Accounts Payable, Current $319.80K.
- 2025-12-31: Accounts Payable, Current $51.52K.
- 2025-09-30: Accounts Payable, Current $19.65K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $139.05K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $319.80K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $51.52K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $19.65K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $106.25K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $36.70K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $15.90K 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.71K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $18.80K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $111.92K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $33.73K 10-K · filed 2025-03-28 |
| 2023-09-30 | $93.15K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $11.75K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $5.01K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $145.16K 10-K · filed 2024-03-29 |
| 2022-09-30 | $326.46K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $311.88K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $321.70K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $279.84K 10-K · filed 2023-03-31 |
| 2021-09-30 | $304.82K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $300.07K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $321.99K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $269.42K 10-K · filed 2022-03-30 |
| 2020-09-30 | $251.53K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $158.51K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $154.24K 10-Q · filed 2020-05-01 |
| 2019-12-31 | $315.94K 10-K · filed 2021-03-26 |
| 2019-09-30 | $285.98K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $195.35K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $245.15K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $384.83K 10-K · filed 2020-03-30 |
| 2018-09-30 | $328.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $326.19K 10-Q · filed 2018-07-23 |
| 2018-03-31 | $370.09K 10-Q · filed 2018-05-01 |
| 2017-12-31 | $534.96K 10-K · filed 2019-03-07 |
| 2017-09-30 | $218.66K 10-Q · filed 2017-10-31 |
| 2017-06-30 | $322.29K 10-Q · filed 2017-07-31 |
| 2017-03-31 | $339.69K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $297.83K 10-K · filed 2018-02-16 |
| 2016-09-30 | $441.49K 10-Q · filed 2016-10-31 |
| 2016-06-30 | $396.05K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $647.11K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $383.36K 10-K · filed 2017-02-17 |
| 2015-09-30 | $442.09K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $246.47K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $493.88K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $324.97K 10-K · filed 2016-02-01 |
| 2014-09-30 | $330.95K 10-Q · filed 2014-10-10 |
| 2014-06-30 | $280.17K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $355.10K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $287.07K 10-K · filed 2015-02-13 |
| 2013-09-30 | $233.26K 10-Q · filed 2013-11-14 |
| 2012-12-31 | $368.61K 10-K · filed 2014-04-15 |